Abstract: A modular swimming pool with one or more swimming pool modules that each include a floor element, and a wall element connected to the floor element. The swimming pool modules by assembly define an internal pool space. The floor element and the wall element of a swimming pool module have reinforcement ribs and the reinforcement ribs of the wall element extend towards the floor element. The reinforcement ribs are spaced apart from each other and on the external surface form open chambers configured, when resting on a mounting surface, to be completely filled with a binder. The internal pool space in the area of the floor element has a wedge-like recess, forming a continuous duct area of the internal pool space, and the reinforcement ribs of the floor element are connected to an external surface of the recess, which faces away from the duct area, thereby restricting the open chambers.

Abstract: A modular swimming pool with one or more swimming pool modules that each include a floor element, and a wall element connected to the floor element. The swimming pool modules by assembly define an internal pool space. The floor element and the wall element of a swimming pool module have reinforcement ribs and the reinforcement ribs of the wall element extend towards the floor element. The reinforcement ribs are spaced apart from each other and on the external surface form open chambers configured, when resting on a mounting surface, to be completely filled with a binder. The internal pool space in the area of the floor element has a wedge-like recess, forming a continuous duct area of the internal pool space, and the reinforcement ribs of the floor element are connected to an external surface of the recess, which faces away from the duct area, thereby restricting the open chambers.

Abstract: The present invention relates to a hypoallergenic molecule consisting of Bet v Ia or an allergen having at least 40% identity to Bet v Ia comprising mutations of at least four amino acid residues in the region of amino acids 100 to 125 of Bet v Ia or its corresponding region of the allergen having at least 40% identity to Bet v 1a.

Abstract: The present invention relates to a variant of a mature polysaccharide lyase having a beta helix structure, wherein said variant comprises an N- and/or C-terminal truncation and consists essentially of at least 90% of the beta helix structure of the mature polysaccharide lyase.

Abstract: An expanded metal is provided including a plurality of integral strands defining diamond shapes, each diamond shape having a long dimension as measured from two opposing vertices and a short dimension, generally transverse to the long direction, as measured between two other opposing vertices, such that the long dimension is less than twice the short dimension.

Abstract: The present invention relates to a hypoallergenic molecule consisting of Bet v Ia or an allergen having at least 40% identity to Bet v Ia comprising mutations of at least four amino acid residues in the region of amino acids 100 to 125 of Bet v Ia or its corresponding region of the allergen having at least 40% identity to Bet v Ia.